Analyst Ratings February 12, 2026

Morgan Stanley Sticks with Overweight on CBRE, Sees Room to Run Despite AI Concerns

Analysts reaffirm bullish ratings as CBRE posts stronger-than-expected Q4 results amid a steep, recent multiple contraction tied to AI worries

By Maya Rios CBRE
Morgan Stanley Sticks with Overweight on CBRE, Sees Room to Run Despite AI Concerns
CBRE

Morgan Stanley has maintained an Overweight rating and a $180 price target on CBRE Group, citing the company's solid fourth-quarter performance and guidance that, while slightly below consensus for 2026, remains above Morgan Stanley's own estimates. The firm expressed surprise at the rapid multiple contraction in the stock as investors debate AI-related disintermediation risks. Other major brokerages have also reiterated bullish views, leaving the analyst consensus range of price targets between $127 and $212.

Key Points

  • Morgan Stanley reaffirmed an Overweight rating on CBRE with a $180 price target, describing the past year as "a solid year" and noting 2026 guidance is slightly below consensus but "well above" Morgan Stanley’s estimates - affects commercial real estate services and financial markets.
  • CBRE beat fourth-quarter EPS expectations at $2.73 versus a $2.68 forecast, while revenue of $11.6 billion was slightly under the $11.67 billion estimate; Jefferies noted core EPS beat both its $2.67 estimate and the $2.72 consensus - impacts corporate earnings and investor sentiment in RE services.
  • Several brokerages including Barclays ($192 PT), Jefferies ($187 PT) and Raymond James ($180 PT) reiterated bullish ratings, highlighting double-digit year-over-year operating profit growth in key segments, which supports confidence in the firm’s multi-segment strength.

Morgan Stanley reiterated an Overweight rating on CBRE Group (NYSE:CBRE) and left its price target at $180, maintaining a favorable view even as market participants weigh potential artificial intelligence-driven disruption in commercial real estate services. The bank described CBRE's recent operating year as "a solid year" and noted that the company’s outlook for 2026, while slightly below consensus, remains "well above" Morgan Stanley’s internal forecasts.

The investment firm said it was surprised by the "magnitude and speed" of the multiple contraction CBRE experienced over a two-day span as investors debate AI disintermediation risks for the services that underlie the commercial real estate sector. According to InvestingPro data cited by analysts, the stock has fallen more than 10% in the last week, and technical indicators indicate the shares may be in oversold territory. InvestingPro also offers 18 additional investment tips for CBRE in its Pro Research Report to help investors navigate the recent volatility.

CBRE’s reported fourth-quarter results exceeded consensus expectations, with earnings per share of $2.73 compared with the forecasted $2.68. Revenue in the quarter came in at $11.6 billion, marginally below the $11.67 billion forecast, but overall performance was characterized as solid. Jefferies' team pointed out that CBRE’s core earnings per share beat both Jefferies’ own estimate of $2.67 and the consensus expectation of $2.72.

Morgan Stanley highlighted that CBRE outperformed its initial guidance last year, suggesting there could be "some conservatism" built into the company’s current outlook. The firm also noted that CBRE views artificial intelligence more as a potential "positive contributor to EBITDA growth and operational efficiencies" rather than an outright threat to its business model, though it acknowledged that AI-related concerns could continue to weigh on the company’s valuation multiple.

Other brokerages have reiterated positive stances on CBRE. Barclays maintained an Overweight rating with a $192 price target and emphasized year-over-year operating profit growth of 14% in the advisory services segment and 20% in the buildings operations & experience segment. Jefferies reiterated a Buy rating and kept a $187 price target, while Raymond James maintained an Outperform rating with a $180 price target, specifically addressing investor worries about AI’s potential impact on commercial real estate.

Taken together, these analyst actions reflect ongoing confidence in CBRE’s segment-level performance despite heightened investor scrutiny over how technological change may alter industry economics. While price targets among analysts vary, the consensus range spans from $127 to $212, a spread that underscores differing assessments of the company’s near-term multiple and longer-term growth trajectory.

Investors continue to debate the net implications of AI for commercial real estate services. On the one hand, management and several analysts highlight potential efficiency gains and incremental EBITDA contribution; on the other hand, market reaction over recent sessions shows how quickly sentiment can shift, producing sharp multiple compression even when core results beat expectations.


What to watch next

  • Whether the company’s 2026 guidance and subsequent quarterly updates show upside to conservative assumptions embedded in current guidance.
  • How investor sentiment around AI-related disintermediation evolves and whether multiple compression stabilizes.
  • Analyst revisions to price targets as more clarity emerges on segment-level performance and efficiency gains attributed to technology initiatives.

Risks

  • Artificial intelligence-related disintermediation risk - investors are debating whether AI could disrupt commercial real estate services, which has already contributed to rapid multiple compression in the stock - impacts commercial real estate and technology-related market assessments.
  • Near-term valuation volatility - CBRE’s stock declined over 10% in the past week and technical indicators suggest the shares may be oversold, reflecting heightened market sensitivity to sentiment shifts - affects equity market volatility and investor risk appetite.
  • Conservative company guidance - Morgan Stanley noted CBRE outperformed its earlier guidance last year and suggested there may be "some conservatism" in the current outlook, meaning future guidance adjustments could alter expectations and market pricing - relevant to corporate earnings forecasts and capital markets.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026